NCT03498456 - Triple Therapy With Tegoprazan in H. Pylori Positive Patients | Biotech Hunter

Enrollment

284

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Helicobacter Pylori Infection

Interventions

DRUG

Tegoprazan/Amoxicillin/Clarithromycin

Tegoprazan 50 mg + Amoxicillin 1000 mg + Clarithromycin 500 mg bid. This therapy will be administered for a total of 7 days, in fasting conditions in the morning and the evening.

DRUG

Lansoprazole/Amoxicillin/Clarithromycin

Lansoprazole 30 mg + Amoxicillin 1000 mg + Clarithromycin 500 mg bid. This therapy will be administered for a total of 7 days, in fasting conditions in the morning and the evening.

Trial Locations (1)

Unknown

Asan Medical Center, Seoul